PPARA and Parkinson disease: Notably, in several preclinical studies using various models of PD and AD, exogenous PEA administration appeared to have neuroprotective effects that are potentially mediated via the PEA-induced PPARα activation, which prevents the overexpression of NFkB, IL1β, and TNFα, thus reducing neuroinflammation (Table 1).